| __timestamp | BioMarin Pharmaceutical Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 4101058 |
| Thursday, January 1, 2015 | 634806000 | 10763215 |
| Friday, January 1, 2016 | 661905000 | 5579049 |
| Sunday, January 1, 2017 | 610753000 | 32051299 |
| Monday, January 1, 2018 | 696328000 | 24482286 |
| Tuesday, January 1, 2019 | 715007000 | 43892589 |
| Wednesday, January 1, 2020 | 628116000 | 44505000 |
| Friday, January 1, 2021 | 628793000 | 79406000 |
| Saturday, January 1, 2022 | 649606000 | 49283000 |
| Sunday, January 1, 2023 | 746773000 | 17282730 |
| Monday, January 1, 2024 | 747184000 |
Data in motion
In the competitive world of pharmaceuticals, innovation is key. BioMarin Pharmaceutical Inc. and Verona Pharma plc are two companies that have consistently invested in research and development (R&D) to drive innovation. From 2014 to 2023, BioMarin has shown a robust commitment to R&D, with expenses peaking in 2023 at approximately $747 million. This represents a significant increase of around 62% from their 2014 investment. In contrast, Verona Pharma's R&D spending, while growing, remains modest in comparison, with a peak of about $79 million in 2021. This is a substantial increase from their 2014 figure, reflecting a nearly 19-fold rise. The data highlights BioMarin's dominant position in innovation investment, consistently outspending Verona Pharma by a wide margin. As the pharmaceutical landscape evolves, these investments could be pivotal in shaping the future of medical breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Verona Pharma plc
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
R&D Insights: How Bristol-Myers Squibb Company and BioMarin Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Zoetis Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Verona Pharma plc Allocate Funds
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Verona Pharma plc
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and Verona Pharma plc
Comparing Innovation Spending: Verona Pharma plc and Geron Corporation